Alumis Correlations

ALMS Stock

26.57 0.03 0.11%

The current 90-days correlation between Alumis Inc and RAPT Therapeutics is 0.14 (i.e., Average diversification). The correlation of Alumis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Alumis Correlation With Market

Very poor diversification

The correlation between Alumis Inc and DJI is 0.81 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alumis Inc and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Alumis Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alumis Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Moving together with Alumis Stock

0.79	GXEA	Galapagos NV Earnings Call This Week	Pair Corr
0.86	8VP1	AVRICORE HEALTH INC	Pair Corr
0.72	VALN	Valneva SE ADR	Pair Corr
0.64	DNLI	Denali Therapeutics	Pair Corr
0.76	DNTH	Dianthus Therapeutics	Pair Corr
0.87	6C1	CytomX Therapeutics	Pair Corr
0.96	DRTS	Alpha Tau Medical	Pair Corr
0.72	DSGN	Design Therapeutics	Pair Corr
0.64	SAB	Sonic Healthcare Earnings Call This Week	Pair Corr
0.94	0P6S	Bayer AG NA	Pair Corr
0.87	DVAX	Dynavax Technologies Earnings Call This Week	Pair Corr

Moving against Alumis Stock

0.8	OSE	OSE Pharma SA	Pair Corr
0.66	RAC	Race Oncology Earnings Call This Week	Pair Corr
0.63	DRMA	Dermata Therapeutics	Pair Corr
0.58	VCYT	Veracyte	Pair Corr
0.51	CDIOW	Cardio Diagnostics	Pair Corr
0.48	VCEL	Vericel Corp Ord	Pair Corr
0.32	ABNX	Abionyx Pharma SA	Pair Corr
0.87	DWTX	Dogwood Therapeutics	Pair Corr
0.83	VKTX	Viking Therapeutics	Pair Corr
0.81	DTIL	Precision BioSciences	Pair Corr
0.8	VSTM	Verastem	Pair Corr
0.79	XE9	Xencor Inc	Pair Corr
0.78	VRAX	Virax Biolabs Group	Pair Corr
0.77	IGS1	India Globalization	Pair Corr
0.73	CDTTW	Conduit Pharmaceuticals	Pair Corr

Related Correlations Analysis

	RAPT	NMRA	ADCT	OCGN	ETON	OMER	FULC	LXRX	BCYC	LCTX
RAPT		0.05	-0.13	0.37	-0.66	0.21	0.0	0.2	-0.45	-0.42	RAPT
NMRA	0.05		0.42	-0.27	0.27	-0.47	-0.45	0.39	-0.47	0.46	NMRA
ADCT	-0.13	0.42		-0.45	0.04	-0.59	-0.11	0.18	-0.1	0.3	ADCT
OCGN	0.37	-0.27	-0.45		-0.42	0.46	-0.03	-0.13	-0.07	-0.23	OCGN
ETON	-0.66	0.27	0.04	-0.42		-0.14	0.03	-0.04	0.23	0.44	ETON
OMER	0.21	-0.47	-0.59	0.46	-0.14		0.2	-0.39	0.0	-0.46	OMER
FULC	0.0	-0.45	-0.11	-0.03	0.03	0.2		-0.24	0.37	-0.23	FULC
LXRX	0.2	0.39	0.18	-0.13	-0.04	-0.39	-0.24		0.17	0.07	LXRX
BCYC	-0.45	-0.47	-0.1	-0.07	0.23	0.0	0.37	0.17		-0.06	BCYC
LCTX	-0.42	0.46	0.3	-0.23	0.44	-0.46	-0.23	0.07	-0.06		LCTX
	RAPT	NMRA	ADCT	OCGN	ETON	OMER	FULC	LXRX	BCYC	LCTX

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LCTX	+ 0.46	NMRA
OMER	+ 0.46	OCGN
LCTX	+ 0.44	ETON
ADCT	+ 0.42	NMRA
LXRX	+ 0.39	NMRA
OCGN	+ 0.37	RAPT

High negative correlations

ETON	- 0.66	RAPT
OMER	- 0.59	ADCT
BCYC	- 0.47	NMRA
OMER	- 0.47	NMRA
LCTX	- 0.46	OMER
OCGN	- 0.45	ADCT

Risk-Adjusted Indicators

There is a big difference between Alumis Stock performing well and Alumis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alumis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RAPT	3.83	1.47	0.33	(0.56)	2.87	(4.58)	7.87	(6.78)	64.19
NMRA	4.17	0.32	0.07	0.47	3.87	(5.47)	10.98	(7.26)	33.25
ADCT	3.16	(0.05)	(0.01)	0.01	4.32	(3.49)	8.49	(7.06)	22.84
OCGN	3.74	0.14	0.02	0.24	4.53	(4.30)	7.25	(7.43)	32.50
ETON	1.85	0.00	(0.01)	0.05	2.37	(2.02)	4.37	(4.16)	13.77
OMER	5.49	1.31	0.24	8.76	4.29	(6.44)	12.62	(7.99)	87.69
FULC	4.34	0.80	0.15	(0.54)	4.00	(5.32)	11.56	(7.75)	53.80
LXRX	3.81	(0.14)	(0.01)	0.01	5.09	(4.69)	9.17	(7.65)	38.53
BCYC	2.69	(0.37)	0.00	(0.23)	0.00	0.00	6.06	(5.88)	14.20
LCTX	3.08	(0.13)	0.00	(0.06)	0.00	0.00	6.04	(5.68)	19.84

Alumis Corporate Management

Grace Halteh	Senior Regulatory	Profile
Kolbot By	Senior Operations	Profile
Jorn MD	Chief Development	Profile
Roman MD	Senior Medicine	Profile
Sara Klein	Chief Secretary	Profile
John CFA	Chief Officer	Profile
Kenneth Brameld	Head Fellow	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC